Title : Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.

Pub. Date : 2004 Nov

PMID : 19667675






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Although such a profile may be achieved with a continuous subcutaneous insulin infusion, new basal insulin analogues, such as once daily, 24-hour insulin glargine, combined with mealtime lispro or aspart, offer comparable glycemic control without the drawbacks of insulin pump use in type 1 diabetes. Insulin Glargine insulin Homo sapiens
2 Although such a profile may be achieved with a continuous subcutaneous insulin infusion, new basal insulin analogues, such as once daily, 24-hour insulin glargine, combined with mealtime lispro or aspart, offer comparable glycemic control without the drawbacks of insulin pump use in type 1 diabetes. Insulin Glargine insulin Homo sapiens
3 Although such a profile may be achieved with a continuous subcutaneous insulin infusion, new basal insulin analogues, such as once daily, 24-hour insulin glargine, combined with mealtime lispro or aspart, offer comparable glycemic control without the drawbacks of insulin pump use in type 1 diabetes. Insulin Glargine insulin Homo sapiens
4 Insulin glargine reduces the frequency of nocturnal hypoglycemia compared with NPH when used with rapid-acting analogues and thus facilitates optimal insulin replacement therapy. Insulin Glargine insulin Homo sapiens
5 Insulin glargine reduces the frequency of nocturnal hypoglycemia compared with NPH when used with rapid-acting analogues and thus facilitates optimal insulin replacement therapy. Insulin Glargine insulin Homo sapiens